A Los Angeles federal judge has declined Tesla and Elon Musk's request to throw out a copyright complaint accusing them of using imagery from the movie "Blade Runner 2049" to create a visual for a ...
Alcon Inc. Chief Executive Officer David Endicott warned that the Trump administration’s push to link US drug prices to those in other countries abroad could result in some medicines not being ...
Alcon is a structurally advantaged ophthalmology leader with a durable equipment-to-consumables model and strong recurring revenue streams. At $72, ALC trades at ~18x forward earnings, reflecting ...
Alcon's installed base anchors a highly attractive stream of high-margin recurring consumables revenue - a classic "razor / razor-blade" model. We believe Alcon's current 20% operating profit margin ...
Alcon is officially ending its PowerVision IOL technology program after disappointing clinical study data. As a result, the Geneva, Switzerland-based company is taking a $402 million write-off related ...
Alcon discontinued the intraocular lens programs it acquired through its 2019 purchase of PowerVision after clinical study data showed persistent unpredictable post-surgical visual outcomes in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Action star Iko Uwais is set to lead “Jakarta,” a multi-generational family crime series in development at Alcon Television Group, with Albert Hughes in negotiations to direct the pilot and serve as ...
Alcon and RxSight have announced a $200 million collaboration to develop post-operative adjustable presbyopic correction intraocular lenses (PCIOLs), marking a strategic pivot for Alcon after years of ...
Nearly a decade after the critical success of Blade Runner 2049, the iconic sci-fi franchise is finally coming back in 2027. However, this time, Blade Runner will be returning in the form of an ...
GENEVA--(BUSINESS WIRE)--Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2026 ...